NanOlogy
  • Home
  • About
  • Technology
  • Development
    • Investigational Drugs
    • Pipeline
    • Clinical Trials
    • Partnering Opportunities
  • News & Publications
    • Recent News Highlights
    • Press Release Archives
    • NanOlogy In the News
    • Presentations & Publications Archive
  • Contact Us
    • Partnering Opportunities
    • Physicians and Patients
Post placeholder image
June 18, 2024 in Publications, Uncategorized

JDDG: Cutaneous metastases: From epidemiology to therapy

NanOlogy 2 Like Post Comments Off on JDDG: Cutaneous metastases: From epidemiology to therapy

Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease April 1 ...

Read More
Post placeholder image
April 26, 2022 in Publications

Breast Cancer Research & Treatment: Phase 1/2 Study of Topical Submicron Particle Paclitaxel for Cutaneous Metastases of Breast Cancer

NanOlogy 1 Like Post Comments Off on Breast Cancer Research & Treatment: Phase 1/2 Study of Topical Submicron Particle Paclitaxel for Cutaneous Metastases of Breast Cancer
Read More
Post placeholder image
December 17, 2020 in Presentations

SABCS 2020 Poster: Phase 1/2 Clinical Trial of A Topical Submicron Particle Paclitaxel (SOR007) for the Treatment of Cutaneous Metastases

NanOlogy 0 Like Post Comments Off on SABCS 2020 Poster: Phase 1/2 Clinical Trial of A Topical Submicron Particle Paclitaxel (SOR007) for the Treatment of Cutaneous Metastases
Read More
Post placeholder image
January 15, 2019 in Presentations

SABCS 2018 Poster: Phase 1/2 Study of Topical SOR007 for Cutaneous Metastases

NanOlogy 0 Like Post Comments Off on SABCS 2018 Poster: Phase 1/2 Study of Topical SOR007 for Cutaneous Metastases

SABCS 2018 Poster: Phase 1/2 Study of Topical SOR007 for Cutaneous Metastases

Read More
NanOlogy

NanOlogy investigational drugs have not yet been proven to be safe and effective in accordance with the requirements of the U.S. FDA and are not approved by FDA or any other jurisdiction for commercial distribution. NanOlogy, NanoPac, and NanoDoce are trademarks of NanOlogy, LLC.    Purcision is a trademark to CritiTech, Inc.  © NanOlogy LLC      Legal